Invention Grant
- Patent Title: Diagnosis of respiratory tract infectious disease using blood specimens
-
Application No.: US15041283Application Date: 2016-02-11
-
Publication No.: US10024869B2Publication Date: 2018-07-17
- Inventor: Kamon Shirakawa
- Applicant: Mochida Pharmaceutical Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: Mochida Pharmaceutical Co., Ltd.
- Current Assignee: Mochida Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2011-112698 20110519
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G01N33/569 ; A61K45/00 ; A61P11/00 ; A61P31/04

Abstract:
According to the methods for detecting respiratory infection associated with bacterial infection of the present invention, the values of soluble CD14 antigen subtype (“sCD14-ST”) in the blood sample can be used to select a patient with a respiratory infection to whom the antibiotic can be administered. The methods of this disclosure can also be used to determine the timing for ending administration of the antibiotic to the patient with respiratory infection.
Public/Granted literature
- US20160161506A1 DIAGNOSIS OF RESPIRATORY TRACT INFECTIOUS DISEASE USING BLOOD SPECIMENS Public/Granted day:2016-06-09
Information query
IPC分类: